Synthetic bone substitute CERAFORM®
for orthopedic surgeryrigid

Synthetic bone substitute - CERAFORM® - Teknimed - for orthopedic surgery / rigid
Synthetic bone substitute - CERAFORM® - Teknimed - for orthopedic surgery / rigid
Synthetic bone substitute - CERAFORM® - Teknimed - for orthopedic surgery / rigid - image - 2
Synthetic bone substitute - CERAFORM® - Teknimed - for orthopedic surgery / rigid - image - 3
Synthetic bone substitute - CERAFORM® - Teknimed - for orthopedic surgery / rigid - image - 4
Add to favorites
Compare this product
 

Characteristics

Type of graft
synthetic
Use
for orthopedic surgery
Shape
rigid

Description

CERAFORM® is a biocompatible and safe synthetic biphasic ceramic made of hydroxyapatite (HA) and beta tricalcium phosphate (β-TCP). Hydroxyapatite Ca10(PO4)6(OH)2 is a calcium phosphate similar to the mineral phase of bone tissue. Tricalcium phosphate Ca3(PO4)2 , more soluble than HA, improves the resorption kinetics of CERAFORM®. CHARACTERISTICS 65% HA / 35% β-TCP Pores size 150-400 µm Interconnected porosity Porosity: 60%-85% for granules or 35%-85% for wedges & sticks INDICATIONS CERAFORM® is indicated for the filling of bone defects due to bone injury (such as tumour, trauma, disease), or surgical procedure (such as arthrodesis, osteotomy). • Granules are indicated for use in tumoral or benign bone cysts (shoulder, hip, knee, foot), fractures (shoulder, knee), osteotomies (knee), and spine fusion procedures, • Sticks are indicated for use in fractures (knee, shoulder), • Wedges are indicated for use in fractures (knee, shoulder). PROPERTIES Biphasic ceramic HA/TCP, the answer to bone defects. SYNTHETIC • Free from organic phase • No immunological risk ABSORBABLE • Absorbed after a minimum of 2 years 1,2,3 BIOCOMPATIBLE • Compliant to ISO 10993-1 4 1. El-Adl G, Ali AM. Does bone marrow affect the radiological outcome when added to biphasic ceramic graft in treatment of benign bone lesions? Eur J Orthop Surg Traumatol. 2013 Jan;23(1):13-20. doi:10.1007/s00590-012-0943-x. Epub 2012 Jan 22. 2. P. Botez, P. Sirbu, L. Simion, Fl. Munteanu, I. Antoniac. Application of a biphasic macroporous synthetic bone substitutes CERAFORM®: clinical and histological results. Eur J Orthop Surg Traumatol (2009) 19:387–395.

Catalogs

Exhibitions

Meet this supplier at the following exhibition(s):

ArabHealth 2025
ArabHealth 2025

27-30 Jan 2025 Dubai (United Arab Emirates) Stand Z2.E38

  • More information
    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.